Evidence mapPaperPMID 41767017Full record

ReviewMolecular and clinical oncology2026

Influence of obesity on breast cancer development in relation to menopausal status (Review).

Ziwen Yang, Ziyuan Sun

Abstract readReview
In one paragraph

Review in Molecular and clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. International journal of molecular sciences · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ziwen YangFirst Clinical Medical College, Shandong Traditional Chinese Medicine University, Jinan, Shandong 250355, P.R. China.
Ziyuan SunFirst Clinical Medical College, Shandong Traditional Chinese Medicine University, Jinan, Shandong 250355, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) ranks as the second most prevalent malignant tumor among women globally, posing a significant threat to female health. Obesity is recognized as an independent risk factor for both the development and progression of BC. Nevertheless, due to the complex mechanism through which obesity affects BC, coupled with the considerable variations in hormone levels, metabolic states, and treatment responses between premenopausal and postmenopausal women, epidemiological studies examining the relationship between obesity and BC incidence often produce inconsistent results. Consequently, it is imperative to stratify analyses by menopausal status to elucidate the specific impact of obesity on BC and to inform targeted prevention strategies.

Indexed as

breast cancermenopausal statusobesity

Identifiers

PMID41767017
PMCPMC12937966

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.